Horizon Discovery

A UK translational genomics company developing and supplying patient-relevant drug discovery and diagnostic reference standards.


We are a fully integrated life science company that provides enabling products, services and research programs to clients engaged at every stage of the healthcare continuum from sequence to treatment.

Horizon was founded by Dr Chris Torrance and Professor Alberto Bardelli in 2007 when they came across an impressive gene editing platform, rAAV, which enabled the ability to tailor-make cell lines with virtually any genomic modification.

Since teaming up in September 2007 with current CEO and President Research Biotech, Dr Darrin M Disley and President Products Dr Paul Morrill, the company has grown rapidly, with offices in the UK, Europe and the U.S., and now supplies advanced research tools and expert services to over 1,400 organizations engaged in genomics research and the development of personalized medicines around the world, including major pharmaceutical, biotechnology and diagnostic companies as well as leading academic research centers.

Back to all supporters

Our latest activities at your fingertips

Be the first the find out about upcoming pop ups in and around Cambridge in 2017 and the latest news on our new space.

Sign up to our newsletter